Clinical trials should be considered at every stage of AML treatment. Clinical trials can provide earlier access to treatments you otherwise could not receive. Remember, today's treatments are yesterday's clinical trials.
Financial — April 10, 2021
Today is National Doctors Day and it's time to take a minute or two to thank your myeloma doctor for their help in your care!
Myeloma 101—April 6, 2021
I clearly remember the early days of my own treatment (7 years ago) for a high-risk myeloma variant. There weren’t enough hours in the day to not just compile the list of questions but to also find the answers.
Coach—April 6, 2021
When your doctor tells you that your multiple myeloma is "in remission", what exactly does that mean? Myeloma experts divide patients into different response categories following treatment according to CIBMTR.
Financial—April 6, 2021
The immunomodulators (thalidomide, lenalidomide and pomalidomide) are a staple class of drugs regularly used in myeloma care. Pomalidomide is often used once patients become resistant to lenalidomide (Revlimid), but how it actually works to kill myeloma has been unclear.
Coach—April 4, 2021
The HealthTree Foundation has launched a #CureinFive initiative for March, Myeloma Awareness Month. Step 4 of that initiative is to participate in and help fund research.
Copyright © 2021 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811